Reaction
Pyogenic Granuloma reporting signals
As of the last recalculation, Pyogenic Granuloma appears in 458 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is PANITUMUMAB (PRR 38.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Panitumumab | 13 | 38.8 | 38.8 |
| Erlotinib | 8 | 38.2 | 38.2 |
| Encorafenib | 8 | 37.4 | 37.4 |
| Erlotinib Hydrochloride | 9 | 33.3 | 33.3 |
| Isotretinoin | 31 | 30.5 | 30.5 |
| Gefitinib | 5 | 25.4 | 25.5 |
| Lapatinib | 5 | 14.8 | 14.8 |
| Abiraterone | 4 | 13.5 | 13.5 |